Cargando…

Clinical and Experimental Factors Influencing the Efficacy of Neurofeedback in ADHD: A Meta-Analysis

Meta-analyses have been extensively used to evaluate the efficacy of neurofeedback (NFB) treatment for Attention Deficit/Hyperactivity Disorder (ADHD) in children and adolescents. However, each meta-analysis published in the past decade has contradicted the methods and results from the previous one,...

Descripción completa

Detalles Bibliográficos
Autores principales: Bussalb, Aurore, Congedo, Marco, Barthélemy, Quentin, Ojeda, David, Acquaviva, Eric, Delorme, Richard, Mayaud, Louis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6388544/
https://www.ncbi.nlm.nih.gov/pubmed/30833909
http://dx.doi.org/10.3389/fpsyt.2019.00035
_version_ 1783397785514541056
author Bussalb, Aurore
Congedo, Marco
Barthélemy, Quentin
Ojeda, David
Acquaviva, Eric
Delorme, Richard
Mayaud, Louis
author_facet Bussalb, Aurore
Congedo, Marco
Barthélemy, Quentin
Ojeda, David
Acquaviva, Eric
Delorme, Richard
Mayaud, Louis
author_sort Bussalb, Aurore
collection PubMed
description Meta-analyses have been extensively used to evaluate the efficacy of neurofeedback (NFB) treatment for Attention Deficit/Hyperactivity Disorder (ADHD) in children and adolescents. However, each meta-analysis published in the past decade has contradicted the methods and results from the previous one, thus making it difficult to determine a consensus of opinion on the effectiveness of NFB. This works brings continuity to the field by extending and discussing the last and much controversial meta-analysis by Cortese et al. (1). The extension comprises an update of that work including the latest control trials, which have since been published and, most importantly, offers a novel methodology. Specifically, NFB literature is characterized by a high technical and methodological heterogeneity, which partly explains the current lack of consensus on the efficacy of NFB. This work takes advantage of this by performing a Systematic Analysis of Biases (SAOB) in studies included in the previous meta-analysis. Our extended meta-analysis (k = 16 studies) confirmed the previously obtained results of effect sizes in favor of NFB efficacy as being significant when clinical scales of ADHD are rated by parents (non-blind, p-value = 0.0014), but not when they are rated by teachers (probably blind, p-value = 0.27). The effect size is significant according to both raters for the subset of studies meeting the definition of “standard NFB protocols” (parents' p-value = 0.0054; teachers' p-value = 0.043, k = 4). Following this, the SAOB performed on k = 33 trials identified three main factors that have an impact on NFB efficacy: first, a more intensive treatment, but not treatment duration, is associated with higher efficacy; second, teachers report a lower improvement compared to parents; third, using high-quality EEG equipment improves the effectiveness of the NFB treatment. The identification of biases relating to an appropriate technical implementation of NFB certainly supports the efficacy of NFB as an intervention. The data presented also suggest that the probably blind assessment of teachers may not be considered a good proxy for blind assessments, therefore stressing the need for studies with placebo-controlled intervention as well as carefully reported neuromarker changes in relation to clinical response.
format Online
Article
Text
id pubmed-6388544
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-63885442019-03-04 Clinical and Experimental Factors Influencing the Efficacy of Neurofeedback in ADHD: A Meta-Analysis Bussalb, Aurore Congedo, Marco Barthélemy, Quentin Ojeda, David Acquaviva, Eric Delorme, Richard Mayaud, Louis Front Psychiatry Psychiatry Meta-analyses have been extensively used to evaluate the efficacy of neurofeedback (NFB) treatment for Attention Deficit/Hyperactivity Disorder (ADHD) in children and adolescents. However, each meta-analysis published in the past decade has contradicted the methods and results from the previous one, thus making it difficult to determine a consensus of opinion on the effectiveness of NFB. This works brings continuity to the field by extending and discussing the last and much controversial meta-analysis by Cortese et al. (1). The extension comprises an update of that work including the latest control trials, which have since been published and, most importantly, offers a novel methodology. Specifically, NFB literature is characterized by a high technical and methodological heterogeneity, which partly explains the current lack of consensus on the efficacy of NFB. This work takes advantage of this by performing a Systematic Analysis of Biases (SAOB) in studies included in the previous meta-analysis. Our extended meta-analysis (k = 16 studies) confirmed the previously obtained results of effect sizes in favor of NFB efficacy as being significant when clinical scales of ADHD are rated by parents (non-blind, p-value = 0.0014), but not when they are rated by teachers (probably blind, p-value = 0.27). The effect size is significant according to both raters for the subset of studies meeting the definition of “standard NFB protocols” (parents' p-value = 0.0054; teachers' p-value = 0.043, k = 4). Following this, the SAOB performed on k = 33 trials identified three main factors that have an impact on NFB efficacy: first, a more intensive treatment, but not treatment duration, is associated with higher efficacy; second, teachers report a lower improvement compared to parents; third, using high-quality EEG equipment improves the effectiveness of the NFB treatment. The identification of biases relating to an appropriate technical implementation of NFB certainly supports the efficacy of NFB as an intervention. The data presented also suggest that the probably blind assessment of teachers may not be considered a good proxy for blind assessments, therefore stressing the need for studies with placebo-controlled intervention as well as carefully reported neuromarker changes in relation to clinical response. Frontiers Media S.A. 2019-02-18 /pmc/articles/PMC6388544/ /pubmed/30833909 http://dx.doi.org/10.3389/fpsyt.2019.00035 Text en Copyright © 2019 Bussalb, Congedo, Barthélemy, Ojeda, Acquaviva, Delorme and Mayaud. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Psychiatry
Bussalb, Aurore
Congedo, Marco
Barthélemy, Quentin
Ojeda, David
Acquaviva, Eric
Delorme, Richard
Mayaud, Louis
Clinical and Experimental Factors Influencing the Efficacy of Neurofeedback in ADHD: A Meta-Analysis
title Clinical and Experimental Factors Influencing the Efficacy of Neurofeedback in ADHD: A Meta-Analysis
title_full Clinical and Experimental Factors Influencing the Efficacy of Neurofeedback in ADHD: A Meta-Analysis
title_fullStr Clinical and Experimental Factors Influencing the Efficacy of Neurofeedback in ADHD: A Meta-Analysis
title_full_unstemmed Clinical and Experimental Factors Influencing the Efficacy of Neurofeedback in ADHD: A Meta-Analysis
title_short Clinical and Experimental Factors Influencing the Efficacy of Neurofeedback in ADHD: A Meta-Analysis
title_sort clinical and experimental factors influencing the efficacy of neurofeedback in adhd: a meta-analysis
topic Psychiatry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6388544/
https://www.ncbi.nlm.nih.gov/pubmed/30833909
http://dx.doi.org/10.3389/fpsyt.2019.00035
work_keys_str_mv AT bussalbaurore clinicalandexperimentalfactorsinfluencingtheefficacyofneurofeedbackinadhdametaanalysis
AT congedomarco clinicalandexperimentalfactorsinfluencingtheefficacyofneurofeedbackinadhdametaanalysis
AT barthelemyquentin clinicalandexperimentalfactorsinfluencingtheefficacyofneurofeedbackinadhdametaanalysis
AT ojedadavid clinicalandexperimentalfactorsinfluencingtheefficacyofneurofeedbackinadhdametaanalysis
AT acquavivaeric clinicalandexperimentalfactorsinfluencingtheefficacyofneurofeedbackinadhdametaanalysis
AT delormerichard clinicalandexperimentalfactorsinfluencingtheefficacyofneurofeedbackinadhdametaanalysis
AT mayaudlouis clinicalandexperimentalfactorsinfluencingtheefficacyofneurofeedbackinadhdametaanalysis